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Lysophosphatidylcholine induces platelet-derived growth fac- of oxLDL. During oxidation of LDL, there is extensive
tor gene expression in a cultured human glomerular mesangial conversion of phosphatidylcholine (PC) to lysoPC. As
cell line. much as 40% of PC of LDL can be converted to lysoPCBackground. Oxidized low-density lipoprotein (oxLDL) has
during oxidative modification [3]. The lysoPC concentra-been considered important in the pathogenesis of progressive
tion is reported to be 10-fold higher in copper-oxidizedrenal injury. Lysophosphatidylcholine (lysoPC) is a major phos-
pholipid component of oxLDL. On the other hand, platelet- LDL [4]. On the other hand, platelet-derived growth
derived growth factor (PDGF) has also been implicated in factor (PDGF) is a potent mitogen for cells of mesenchy-
proliferative disease of the kidney. This study investigated the mal origin and is a dimeric peptide composed of a hetero-difference in the potential of PC and lysoPC to induce DNA
dimer of A and B chains (referred to as PDGF-AB) orsynthesis and PDGF gene expression in a human glomerular
homodimers of either chains (referred to as PDGF-AAmesangial cell line (HMCL).
Methods. DNA synthesis in HMCL was measured by [3H] and -BB). This mitogen is released and/or synthesized
thymidine incorporation. The mRNA expression levels of the by platelets, macrophages, and endothelial cells. Glo-
PDGF A chain and B chain genes were measured using reverse merular mesangial cells in culture have also been showntranscription-polymerase chain reaction.
to release a PDGF-like molecule into their media andResults. LysoPC treatment up-regulated the [3H] thymidine
to express the mRNA for both PDGF-A chain and -Bincorporation level in a dose-dependent fashion. The [3H] thy-
midine incorporation level in HMCL coincubated with lysoPC chain [5, 6]. PDGF has been implicated in several non-
started to increase after 4 hours of treatment, peaked at 24 malignant pathophysiological processes, including prolif-
hours, and decreased thereafter. The level in HMCL incubated erative disease of the kidney. This study investigated thewith 100 mm of lysoPC (palmitoyl or stearoyl) increased to
differences in the potential of PC and lysoPC to induce7- or 10-fold of the control at peak time, respectively. However,
DNA synthesis and the expression of PDGF A chainPC treatment did not increase [3H] thymidine incorporation in
HMCL. PC treatment did not induce mRNA expression of and B chain mRNA in a human glomerular mesangial
either PDGF A or B chain genes. LysoPC did not induce cell line (HMCL).
PDGF A chain mRNA expression either. The only B chain
mRNA expression was induced by lysoPC. The mRNA expres-
sion level in HMCL treated with 50 mm lysoPC for two hours METHODS
increased to 1.6-fold that of the control.
The HMCL was kindly provided by Dr. Jean-DanielConclusion. LysoPC may induce DNA synthesis in a mesan-
gial cell through the induction of PDGF BB as an autocrine Sraer [7]. LysoPC [palmitoyl (LP) and stearoyl (LS)]
and paracrine growth factor. and PC [dipalmitoyl (PP) and distearoyl (PS)] were pur-
chased from Sigma Chemical Co. (St. Louis, MO, USA).
[3H] thymidine was obtained from Amersham (Arlington
Many investigators have demonstrated that abnormal- Heights, IL, USA). Reverse transcription-polymerase
ities in lipid metabolism may contribute to mesangial chain reaction (RT-PCR) reagents were purchased from
hypercellularity, mesangial matrix accumulation, and Roche Molecular Systems, Inc. (Branchburg, NJ, USA).
glomerular sclerosis [1, 2]. Oxidized low-density lipopro-
DNA synthesis level in human glomerular mesangialtein (oxLDL) has also been considered important in the
cell linepathogenesis of progressive renal injury. Lysophosphati-
dylcholine (lysoPC) is a major phospholipid component DNA synthesis in HMCL was measured by [3H] thymi-
dine incorporation. After 48 hours of starvation, HMCL
was treated with 0, 12.5, 25, 50, or 100 mm of PC orKey words: glomerular mesangial cell, PDGF, [3H] thymidine incorpo-
ration, RT-PCR. lysoPC for 24 hours to determine the dose-response of
DNA synthesis. The cells were also treated with 50 mm 1999 by the International Society of Nephrology
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Fig. 1. The potential of phosphatidylcholine
(PC) and lysophosphatidylcholine (lysoPC) to
induce [3H] thymidine incorporation. LysoPC
treatment up-regulated the [3H] thymidine in-
corporation level in (A) a dose- and (B) time-
dependent fashion in human glomerular mes-
angial cell line (HMCL). PC treatment did not
increase [3H] thymidine incorporation (A, B).
The control values were at 0 mm of PC or
lysoPC. Data express mean 6 se.
of PC or lysoPC for 0, 4, 8, 12, 24, or 48 hours to deter- the cells was isolated according to the acid guanidium
mine the time course of DNA synthesis. [3H] thymidine thiocyanate procedure. RT-PCR was performed ac-
incorporation into the cellular DNA was determined by cording to the manufacturer’s instructions. The products
adding 10 mCi/ml [3H] thymidine together with the agents were electophoresed on a 1.2% agarose gel containing
being tested for stimulation. After harvesting the cells, ethidium bromide. The products were quantitated using
radioactivity was assayed in a liquid scintillation counter. an ultraviolet transilluminator. The PDGF mRNA ex-
pression levels were normalized against the b-actin ex-
The mRNA expression levels of platelet-derived pression level.
growth factor A chain and B chain genes
The mRNA expression levels of PDGF A chain, B
RESULTSchain, and b-actin were measured using RT-PCR. After
We investigated the difference in the potential of PC48 hours of starvation, HMCL was treated with 0, 12.5,
25, or 50 mm of PC or lysoPC for 2 hours. Total RNA from and lysoPC to induce DNA synthesis in HMCL by [3H]
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Fig. 2. The potential of phosphatidylcholine (PC) and lysophosphatidylcholine (lysoPC) to induce platelet-derived growth factor (PDGF) gene
expression. PC treatment did not induce the mRNA expression of either PDGF A or B chains in human glomerular mesangial cell line (HMCL).
LysoPC did not induce PDGF A chain mRNA expression but did induce B chain mRNA expression. The control values were at 0 mm of PC or
lysoPC. These data are representative of three replicate experiments.
thymidine incorporation. As shown in Figure 1A, lysoPC chain or B chains in HMCL (Fig. 2A). LysoPC did not
treatment up-regulated the [3H] thymidine incorporation induce PDGF A chain mRNA expression, either. The
level in a dose-dependent fashion during 24-hour coincu- only B chain mRNA expression was induced by lysoPC.
bation. The [3H] thymidine incorporation level in HMCL The PDGF B chain mRNA expression level in HMCL
started to increase after 4 hours of the lysoPC treatment, treated with 50 mm lysoPC for two hours increased to
peaked at 24 hours, and decreased thereafter (Fig. 1B). 1.6-fold that of the control (Fig. 2B).
The level in HMCL coincubated with 100 mm LP or LS
increased to 7- or 10-fold that of control at peak time,
DISCUSSIONrespectively. On the other hand, PC treatment did not
Oxidized LDL has been shown to cause multipleincrease the [3H] thymidine incorporation level in HMCL.
changes in cellular functions, distinct from the effects of
Potential of phosphatidylcholine and native LDL (nLDL). During oxidation of LDL, there is
lysophosphatidylcholine to induce extensive conversion of PC to lysoPC. We investigated
PDGF gene expression the difference in the potential of PC and lysoPC to induce
DNA synthesis in HMCL. LysoPC treatment up-regu-We also investigated the difference in the potential of
lated the [3H] thymidine incorporation level in a dose-PC and lysoPC to induce the expression of PDGF A
and time-dependent fashion. The toxicity of lysoPC maychain and B chain mRNA in HMCL. PC treatment did
not induce the mRNA expression of either PDGF A have decreased the [3H] thymidine incorporation in the
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cells incubated with 50 mm lysoPC for 48 hours. On lysoPC. In other words, these results suggest that lysoPC
induces mesangial cell DNA synthesis through the induc-the other hand, PC treatment did not increase the [3H]
tion of PDGF BB as an autocrine and paracrine growththymidine incorporation level in HMCL. These results
factor.indicate that lysoPC functions to induce DNA synthesis
in HMCL, whereas PC does not. DNA synthesis is one Reprint requests to Haruhisa Otani, M.D., The Third Department
of the indicators of cell proliferation. The difference in of Internal Medicine, Wakayama Medical College, 811-1 Kimiidera,
Wakayama 641-0012, Japan.lysoPC concentration in nLDL and oxLDL has been
E-mail: hotani@wakayama-med.ac.jphypothesized to relate to the difference in mesangial cell
proliferation in proliferative renal disease. Interestingly, REFERENCES
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